Pub Date : 2023-01-01DOI: 10.1080/09553002.2022.2110301
Delphine Avril, Jean-Philippe Foy, Jebrane Bouaoud, Vincent Grégoire, Pierre Saintigny
Purpose: Head and neck squamous cell carcinoma (HNSCC) is a major cause of morbidity and mortality. Although HNSCC is mainly caused by tobacco and alcohol consumption, infection by Human Papilloma Virus (HPV) has been also associated with the increasing incidence of oropharyngeal squamous cell carcinomas (OPSCC) during the past decades. HPV-positive HNSCC is characterized by a higher radiosensitivity compared to HPV-negative tumor. While several clinical trials are evaluating de-escaladed radiation doses strategies in HPV-positive HNSCC, molecular mechanisms associated with relative radioresistance in HPV-negative HNSCC are still broadly unknown. Our goal was to review recently proposed biomarkers of radioresistance in this setting, which may be useful for stratifying tumor's patient according to predicted level of radioresistance.
Conclusions: most of biomarkers of radioresistance in HPV-negative HNSCC are identified using a hypothesis-driven approach, based on molecular mechanisms known to play a key role during carcinogenesis, compared to an unsupervised data-driven approach regardless the biological rational. DNA repair and hypoxia are the two most widely investigated biological and targetable pathways related to radioresistance in HNSCC. The better understanding of molecular mechanisms and biomarkers of radioresistance in HPV-negative HNSCC could help for the development of radiosensitization strategies, based on targetable biomarkers, in radioresistant tumors as well as de-escalation radiation dose strategies, based on biological level of radioresistance, in radiosensitive tumors.
{"title":"Biomarkers of radioresistance in head and neck squamous cell carcinomas.","authors":"Delphine Avril, Jean-Philippe Foy, Jebrane Bouaoud, Vincent Grégoire, Pierre Saintigny","doi":"10.1080/09553002.2022.2110301","DOIUrl":"https://doi.org/10.1080/09553002.2022.2110301","url":null,"abstract":"<p><strong>Purpose: </strong>Head and neck squamous cell carcinoma (HNSCC) is a major cause of morbidity and mortality. Although HNSCC is mainly caused by tobacco and alcohol consumption, infection by Human Papilloma Virus (HPV) has been also associated with the increasing incidence of oropharyngeal squamous cell carcinomas (OPSCC) during the past decades. HPV-positive HNSCC is characterized by a higher radiosensitivity compared to HPV-negative tumor. While several clinical trials are evaluating de-escaladed radiation doses strategies in HPV-positive HNSCC, molecular mechanisms associated with relative radioresistance in HPV-negative HNSCC are still broadly unknown. Our goal was to review recently proposed biomarkers of radioresistance in this setting, which may be useful for stratifying tumor's patient according to predicted level of radioresistance.</p><p><strong>Conclusions: </strong>most of biomarkers of radioresistance in HPV-negative HNSCC are identified using a hypothesis-driven approach, based on molecular mechanisms known to play a key role during carcinogenesis, compared to an unsupervised data-driven approach regardless the biological rational. DNA repair and hypoxia are the two most widely investigated biological and targetable pathways related to radioresistance in HNSCC. The better understanding of molecular mechanisms and biomarkers of radioresistance in HPV-negative HNSCC could help for the development of radiosensitization strategies, based on targetable biomarkers, in radioresistant tumors as well as de-escalation radiation dose strategies, based on biological level of radioresistance, in radiosensitive tumors.</p>","PeriodicalId":14261,"journal":{"name":"International Journal of Radiation Biology","volume":"99 4","pages":"583-593"},"PeriodicalIF":2.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9498858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To encourage the use of the NTCP0 for evaluating safety as a new alternative of assessing the S-Es of the radiation oncology treatments; and the use of the 'NTCP0cal' methodology that calculates/estimates NTCP0.
Method: Revisions of studies related to use of the NTCP in the evaluations of S-Es. Development of the first version of the Matlab application of our methodology, which provides three options, two of them employ the well-known aspects of a phenomenological model, or the relationship with the TNTCP; where NTCP0 = 100%-TNTCP; and the third option determines NTCP0 from an assumed NTCP discrete probabilistic distribution from the binomial distribution, where one of its parameters is automatically defined from a databased of the Disease locations Vs. Late complications.
Result: As result of revisions of some QUANTEC studies, we can say that: (1) The majority of current NTCP models are DVH-based; (2) The risk of toxicity is the way of evaluating the S-Es of the radiation oncology treatments; and (3) The NTCP are used mainly for evaluations of individual or principal complications or Endpoints of the radiation treatments. The 'NTCP0cal' Matlab application developed in this study has three calculation options. Two of the options provide additional graphical information about the distributions.
Conclusions: The NTCP0 is a new radiobiological concept, its introduction let to correct some current P + and UTCP formulations, and will allow evaluating S-Es in whatever activity involving ionizing radiation, like radiation treatments; and its phenomenological model function of dose prescribed (D = n*d) will allow calculating values of NTCP0 for a range of dose per fraction (d) in a treatment with a determined number of fractions (n), or for range of n for a constant d. The DVH is irrelevant for this model. For whatever radiation treatment given to a population of similar patients under similar circumstances, the NTCP0 is calculated as ratio of the number of patients without acute/late complications and total of them. When this number is unknown, then NTCP0 can be obtained using the 'NTCP0cal' application.
{"title":"The use of the normal tissue non-complication probability (NTCP0) in the safety evaluations as a new alternative of assessing the side-effects of the radiation oncology treatments.","authors":"Terman Frometa-Castillo, Anil Pyakuryal, Ganesh Narayanasamy, Amadeo Wals-Zurita, Asghar Mesbahi","doi":"10.1080/09553002.2022.2110299","DOIUrl":"https://doi.org/10.1080/09553002.2022.2110299","url":null,"abstract":"<p><strong>Purpose: </strong>To encourage the use of the NTCP0 for evaluating safety as a new alternative of assessing the S-Es of the radiation oncology treatments; and the use of the 'NTCP0cal' methodology that calculates/estimates NTCP0.</p><p><strong>Method: </strong>Revisions of studies related to use of the NTCP in the evaluations of S-Es. Development of the first version of the Matlab application of our methodology, which provides three options, two of them employ the well-known aspects of a phenomenological model, or the relationship with the TNTCP; where NTCP0 = 100%-TNTCP; and the third option determines NTCP0 from an assumed NTCP discrete probabilistic distribution from the binomial distribution, where one of its parameters is automatically defined from a databased of the Disease locations Vs. Late complications.</p><p><strong>Result: </strong>As result of revisions of some QUANTEC studies, we can say that: (1) The majority of current NTCP models are DVH-based; (2) The risk of toxicity is the way of evaluating the S-Es of the radiation oncology treatments; and (3) The NTCP are used mainly for evaluations of individual or principal complications or Endpoints of the radiation treatments. The 'NTCP0cal' Matlab application developed in this study has three calculation options. Two of the options provide additional graphical information about the distributions.</p><p><strong>Conclusions: </strong>The NTCP0 is a new radiobiological concept, its introduction let to correct some current P + and UTCP formulations, and will allow evaluating S-Es in whatever activity involving ionizing radiation, like radiation treatments; and its phenomenological model function of dose prescribed (D = n*d) will allow calculating values of NTCP0 for a range of dose per fraction (d) in a treatment with a determined number of fractions (n), or for range of <i>n</i> for a constant <i>d</i>. The DVH is irrelevant for this model. For whatever radiation treatment given to a population of similar patients under similar circumstances, the NTCP0 is calculated as ratio of the number of patients without acute/late complications and total of them. When this number is unknown, then NTCP0 can be obtained using the 'NTCP0cal' application.</p>","PeriodicalId":14261,"journal":{"name":"International Journal of Radiation Biology","volume":"99 4","pages":"656-662"},"PeriodicalIF":2.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9814373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1080/09553002.2023.2146231
Irina V Panyutin, Paul G Wakim, Roberto Maass-Moreno, William F Pritchard, Ronald D Neumann, Igor G Panyutin
Purpose: We studied the effects of computed tomography (CT) scan irradiation on proliferation and differentiation of human embryonic stem cells (hESCs). It was reported that hESC is extremely radiosensitive; exposure of hESC in cultures to 1 Gy of ionizing radiation (IR) results in massive apoptosis of the damaged cells and, thus, they are eliminated from the cultures. However, after recovery the surviving cells proliferate and differentiate normally. We hypothesized that IR-exposed hESC may still have growth rate disadvantage when they proliferate or differentiate in the presence of non-irradiated hESC, as has been shown for mouse hematopoietic stem cells in vivo.
Materials and methods: To study such competitive proliferation and differentiation, we obtained cells of H9 hESC line that stably express green fluorescent protein (H9GFP). Irradiated with 50 mGy or 500 mGy H9GFP and non-irradiated H9 cells (or vice versa) were mixed and allowed to grow under pluripotency maintaining conditions or under conditions of directed differentiation into neuronal lineage for several passages. The ratio of H9GFP to H9 cells was measured after every passage or approximately every week.
Results: We observed competition of H9 and H9GFP cells; we found that the ratio of H9GFP to H9 cells increased with time in both proliferation and differentiation conditions regardless of irradiation, i.e. the H9GFP cells in general grew faster than H9 cells in the mixtures. However, we did not observe any consistent changes in the relative growth rate of irradiated versus non-irradiated hESC.
Conclusions: We conclude that population of pluripotent hESC is very resilient; while damaged cells are eliminated from colonies, the surviving cells retain their pluripotency, ability to differentiate, and compete with non-irradiated isogenic cells. These findings are consistent with the results of our previous studies, and with the concept that early in pregnancy omnipotent cells injured by IR can be replaced by non-damaged cells with no impact on embryo development.
{"title":"Effect of exposure to ionizing radiation on competitive proliferation and differentiation of hESC.","authors":"Irina V Panyutin, Paul G Wakim, Roberto Maass-Moreno, William F Pritchard, Ronald D Neumann, Igor G Panyutin","doi":"10.1080/09553002.2023.2146231","DOIUrl":"https://doi.org/10.1080/09553002.2023.2146231","url":null,"abstract":"<p><strong>Purpose: </strong>We studied the effects of computed tomography (CT) scan irradiation on proliferation and differentiation of human embryonic stem cells (hESCs). It was reported that hESC is extremely radiosensitive; exposure of hESC in cultures to 1 Gy of ionizing radiation (IR) results in massive apoptosis of the damaged cells and, thus, they are eliminated from the cultures. However, after recovery the surviving cells proliferate and differentiate normally. We hypothesized that IR-exposed hESC may still have growth rate disadvantage when they proliferate or differentiate in the presence of non-irradiated hESC, as has been shown for mouse hematopoietic stem cells in vivo.</p><p><strong>Materials and methods: </strong>To study such competitive proliferation and differentiation, we obtained cells of H9 hESC line that stably express green fluorescent protein (H9GFP). Irradiated with 50 mGy or 500 mGy H9GFP and non-irradiated H9 cells (or vice versa) were mixed and allowed to grow under pluripotency maintaining conditions or under conditions of directed differentiation into neuronal lineage for several passages. The ratio of H9GFP to H9 cells was measured after every passage or approximately every week.</p><p><strong>Results: </strong>We observed competition of H9 and H9GFP cells; we found that the ratio of H9GFP to H9 cells increased with time in both proliferation and differentiation conditions regardless of irradiation, i.e. the H9GFP cells in general grew faster than H9 cells in the mixtures. However, we did not observe any consistent changes in the relative growth rate of irradiated versus non-irradiated hESC.</p><p><strong>Conclusions: </strong>We conclude that population of pluripotent hESC is very resilient; while damaged cells are eliminated from colonies, the surviving cells retain their pluripotency, ability to differentiate, and compete with non-irradiated isogenic cells. These findings are consistent with the results of our previous studies, and with the concept that early in pregnancy omnipotent cells injured by IR can be replaced by non-damaged cells with no impact on embryo development.</p>","PeriodicalId":14261,"journal":{"name":"International Journal of Radiation Biology","volume":"99 5","pages":"760-768"},"PeriodicalIF":2.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9814397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1080/09553002.2023.2176563
Andrea L DiCarlo, David R Cassatt, Carmen I Rios, Merriline M Satyamitra, Yuji Zhang, Trevor G Golden, Lanyn P Taliaferro
Abstract Purpose The intent of this mini review is to pay homage to Dr. John E. Moulder’s long and successful career in radiation science with the Medical College of Wisconsin. This effort will be done from the perspective of his history of U.S. Government funding for research into the biological pathways involved in radiation-induced normal tissue injuries, especially damage to the kidneys and heart, and pharmacological interventions. In addition, the impact of his steady guidance and leadership in the mentoring of junior scientists, and the development of meaningful collaborations with other researchers will be highlighted. Conclusion Dr. John E. Moulder’s contributions to the field of radiation research, through his strong character and reputation, his consistent and dedicated commitment to his colleagues and students, and his significant scientific advances, have been critical to moving the science forward, and will not be forgotten by those who knew him personally or through publications documenting his important work.
{"title":"Making connections: the scientific impact and mentoring legacy of Dr. John E. Moulder.","authors":"Andrea L DiCarlo, David R Cassatt, Carmen I Rios, Merriline M Satyamitra, Yuji Zhang, Trevor G Golden, Lanyn P Taliaferro","doi":"10.1080/09553002.2023.2176563","DOIUrl":"https://doi.org/10.1080/09553002.2023.2176563","url":null,"abstract":"Abstract Purpose The intent of this mini review is to pay homage to Dr. John E. Moulder’s long and successful career in radiation science with the Medical College of Wisconsin. This effort will be done from the perspective of his history of U.S. Government funding for research into the biological pathways involved in radiation-induced normal tissue injuries, especially damage to the kidneys and heart, and pharmacological interventions. In addition, the impact of his steady guidance and leadership in the mentoring of junior scientists, and the development of meaningful collaborations with other researchers will be highlighted. Conclusion Dr. John E. Moulder’s contributions to the field of radiation research, through his strong character and reputation, his consistent and dedicated commitment to his colleagues and students, and his significant scientific advances, have been critical to moving the science forward, and will not be forgotten by those who knew him personally or through publications documenting his important work.","PeriodicalId":14261,"journal":{"name":"International Journal of Radiation Biology","volume":"99 7","pages":"1009-1015"},"PeriodicalIF":2.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10330047/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9822241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01Epub Date: 2023-03-15DOI: 10.1080/09553002.2023.2187474
Wei Zhang, Richard G E Haylock, Michael Gillies, Nezahat Hunter, Erica Zhang
Purpose: While some evidence of an effect of radiation exposure on respiratory disease at low dose levels has now emerged, there is heterogeneity in the risks between different studies and countries. In this paper, we aim to show the effect of radiation on three different sub-types of respiratory disease mortality through the analysis of the NRRW cohort in UK.
Materials and methods: The NRRW cohort consisted of 174,541 radiation workers. Doses to the surface of the body were monitored using individual film badges. Most of the doses are associated with X-rays and gamma rays and to a less extent of beta and neutron particles. The overall mean 10-year lagged lifetime external dose was 23.2 mSv. Some workers were potentially exposed to alpha particles. However, doses from internal emitters were not available for the NRRW cohort. 25% of male workers and 17% of female workers were identified as being monitored for internal exposure. The Poisson regression methods for grouped survival data with a stratified baseline hazard function were used to describe the dependence of the risk on cumulative external radiation dose. The disease was analyzed by the following subgroups: Pneumonia (1066 cases including 17 cases of influenza), COPD and allied disease (1517 cases) and other remaining respiratory diseases (479 cases).
Results: There was very little radiation effect on pneumonia mortality, but evidence of a reduction in mortality risk for COPD and allied disease (ERR/Sv= -0.56, 95%CI: -0.94, -0.06; p = .02) and an increase in risk for other respiratory disease mortality (ERR/Sv = 2.30, 95%CI: 0.67, 4.62; p = .01) with increasing cumulative external dose were observed. The effects of radiation were more prominent amongst workers monitored for internal exposure. The reduction in mortality risk of COPD and allied disease per cumulative external dose was statistically significant for the radiation workers monitored for internal exposure (ERR/Sv= -0.59, 95%CI: -0.99, -0.05; p = .017) but not significant among the workers who were not monitored (ERR/Sv= -0.43, 95%CI: -1.20, 0.74; p = .42). A statistically significant increased risk was observed for other respiratory diseases among monitored radiation workers (ERR/Sv = 2.46, 95%CI: 0.69, 5.08; p = .019), but not among unmonitored workers (ERR/Sv = 1.70, 95%CI: -0.82, 5.65; p = .25).
Conclusion: The effects of radiation exposure can be different depending on the type of respiratory disease. No effect was seen in pneumonia; a reduction in mortality risk of COPD, and increased mortality risk of other respiratory diseases were observed with cumulative external radiation dose. More studies are needed to verify these findings.
{"title":"Effects of radiation on respiratory disease mortality: analysis of the national registry for radiation workers in United Kingdom.","authors":"Wei Zhang, Richard G E Haylock, Michael Gillies, Nezahat Hunter, Erica Zhang","doi":"10.1080/09553002.2023.2187474","DOIUrl":"10.1080/09553002.2023.2187474","url":null,"abstract":"<p><strong>Purpose: </strong>While some evidence of an effect of radiation exposure on respiratory disease at low dose levels has now emerged, there is heterogeneity in the risks between different studies and countries. In this paper, we aim to show the effect of radiation on three different sub-types of respiratory disease mortality through the analysis of the NRRW cohort in UK.</p><p><strong>Materials and methods: </strong>The NRRW cohort consisted of 174,541 radiation workers. Doses to the surface of the body were monitored using individual film badges. Most of the doses are associated with X-rays and gamma rays and to a less extent of beta and neutron particles. The overall mean 10-year lagged lifetime external dose was 23.2 mSv. Some workers were potentially exposed to alpha particles. However, doses from internal emitters were not available for the NRRW cohort. 25% of male workers and 17% of female workers were identified as being monitored for internal exposure. The Poisson regression methods for grouped survival data with a stratified baseline hazard function were used to describe the dependence of the risk on cumulative external radiation dose. The disease was analyzed by the following subgroups: Pneumonia (1066 cases including 17 cases of influenza), COPD and allied disease (1517 cases) and other remaining respiratory diseases (479 cases).</p><p><strong>Results: </strong>There was very little radiation effect on pneumonia mortality, but evidence of a reduction in mortality risk for COPD and allied disease (ERR/Sv= -0.56, 95%CI: -0.94, -0.06; <i>p</i> = .02) and an increase in risk for other respiratory disease mortality (ERR/Sv = 2.30, 95%CI: 0.67, 4.62; <i>p</i> = .01) with increasing cumulative external dose were observed. The effects of radiation were more prominent amongst workers monitored for internal exposure. The reduction in mortality risk of COPD and allied disease per cumulative external dose was statistically significant for the radiation workers monitored for internal exposure (ERR/Sv= -0.59, 95%CI: -0.99, -0.05; <i>p</i> = .017) but not significant among the workers who were not monitored (ERR/Sv= -0.43, 95%CI: -1.20, 0.74; <i>p</i> = .42). A statistically significant increased risk was observed for other respiratory diseases among monitored radiation workers (ERR/Sv = 2.46, 95%CI: 0.69, 5.08; <i>p</i> = .019), but not among unmonitored workers (ERR/Sv = 1.70, 95%CI: -0.82, 5.65; <i>p</i> = .25).</p><p><strong>Conclusion: </strong>The effects of radiation exposure can be different depending on the type of respiratory disease. No effect was seen in pneumonia; a reduction in mortality risk of COPD, and increased mortality risk of other respiratory diseases were observed with cumulative external radiation dose. More studies are needed to verify these findings.</p>","PeriodicalId":14261,"journal":{"name":"International Journal of Radiation Biology","volume":" ","pages":"1531-1541"},"PeriodicalIF":2.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9112251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1080/09553002.2022.2074755
Katherine A Vallis, Roger F Martin, Nadia Falzone
The 9th International Symposium on Physical, Molecular, Cellular, and Medical Aspects of Auger Processes took place from 22nd to 24th August 2019. This is a quadrennial event that has traditionally been held as a ‘satellite’ meeting of the International Congress for Radiation Research. Removal of an inner orbital electron through the photoelectric effect, electron capture, or internal conversion leads to a vacancy which is then filled by a cascade of electron transitions from the outer shells. These transitions are accompanied by the emission of low energy ‘Auger’ electrons or characteristic X-rays. Auger electrons have low energy (<25 keV), have a short track length and are densely ionizing. As a result, the absorbed radiation dose they deposit in biological material is extremely high but restricted to a nanoscale volume (a few nm) around the decay site. These qualities mean that Auger electron emitting radionuclides are suited to the ultra-precise delivery of radiation to individual cells, organelles or even to specific molecular targets, and so hold promise as oncologic therapeutic agents. The 9th Auger Symposium opened with a plenary presentation by Roger Howell, Rutgers University, who gave a comprehensive exposition of the advances in the use of Auger electrons in science and medicine during the period 2015–2019. The rest of the programme was organized into five scientific sessions focused on the availability and characteristics of ‘new’ Auger electron emitting radionuclides, physics, radiobiology, dosimetry and novel applications. Each session was headed by presentations by leaders in the field followed by selected papers from among submitted abstracts. Some of the research presented at the meeting has now been published as a collection of papers, together with a review article by Roger Howell summarizing his Keynote talk, in this ‘Special Auger Issue’ of the International Journal of Radiation Biology. The current series of Auger Symposia was inaugurated in 1987, when a group of radiation biologists and nuclear physicists met at the modest venue of the Oxfordshire village of Charney Bassett. It felt apt then that the 9th Symposium, which attracted 60 scientists from 13 countries, returned to Oxfordshire, although this time convening in the stunning Sultan Nazrin Shah Center located in the grounds of Worcester College, Oxford University. The scientific sessions were punctuated by opportunities for attendees to network and to enjoy some late summer sunshine and the tranquility of the College gardens and orchards. We would like to thank the other members of the organizing committee (Ana Denis-Bacelar, Bart Cornelissen, Samantha Terry and Akinari Yokoya) for their contributions, Anne-Marie Honeyman-Tafa for administrative assistance and Theragostics and the Gray Laboratory Cancer Research Trust for their sponsorship of the meeting. Auger electrons were independently identified by the physicists Lise Meitner and Pierre Auger; with Pierre Auger’
{"title":"9th international symposium on physical, molecular, cellular, and medical aspects of Auger processes: preface.","authors":"Katherine A Vallis, Roger F Martin, Nadia Falzone","doi":"10.1080/09553002.2022.2074755","DOIUrl":"https://doi.org/10.1080/09553002.2022.2074755","url":null,"abstract":"The 9th International Symposium on Physical, Molecular, Cellular, and Medical Aspects of Auger Processes took place from 22nd to 24th August 2019. This is a quadrennial event that has traditionally been held as a ‘satellite’ meeting of the International Congress for Radiation Research. Removal of an inner orbital electron through the photoelectric effect, electron capture, or internal conversion leads to a vacancy which is then filled by a cascade of electron transitions from the outer shells. These transitions are accompanied by the emission of low energy ‘Auger’ electrons or characteristic X-rays. Auger electrons have low energy (<25 keV), have a short track length and are densely ionizing. As a result, the absorbed radiation dose they deposit in biological material is extremely high but restricted to a nanoscale volume (a few nm) around the decay site. These qualities mean that Auger electron emitting radionuclides are suited to the ultra-precise delivery of radiation to individual cells, organelles or even to specific molecular targets, and so hold promise as oncologic therapeutic agents. The 9th Auger Symposium opened with a plenary presentation by Roger Howell, Rutgers University, who gave a comprehensive exposition of the advances in the use of Auger electrons in science and medicine during the period 2015–2019. The rest of the programme was organized into five scientific sessions focused on the availability and characteristics of ‘new’ Auger electron emitting radionuclides, physics, radiobiology, dosimetry and novel applications. Each session was headed by presentations by leaders in the field followed by selected papers from among submitted abstracts. Some of the research presented at the meeting has now been published as a collection of papers, together with a review article by Roger Howell summarizing his Keynote talk, in this ‘Special Auger Issue’ of the International Journal of Radiation Biology. The current series of Auger Symposia was inaugurated in 1987, when a group of radiation biologists and nuclear physicists met at the modest venue of the Oxfordshire village of Charney Bassett. It felt apt then that the 9th Symposium, which attracted 60 scientists from 13 countries, returned to Oxfordshire, although this time convening in the stunning Sultan Nazrin Shah Center located in the grounds of Worcester College, Oxford University. The scientific sessions were punctuated by opportunities for attendees to network and to enjoy some late summer sunshine and the tranquility of the College gardens and orchards. We would like to thank the other members of the organizing committee (Ana Denis-Bacelar, Bart Cornelissen, Samantha Terry and Akinari Yokoya) for their contributions, Anne-Marie Honeyman-Tafa for administrative assistance and Theragostics and the Gray Laboratory Cancer Research Trust for their sponsorship of the meeting. Auger electrons were independently identified by the physicists Lise Meitner and Pierre Auger; with Pierre Auger’","PeriodicalId":14261,"journal":{"name":"International Journal of Radiation Biology","volume":"99 1","pages":"1"},"PeriodicalIF":2.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9150444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1080/09553002.2022.2074564
Dennis Leeper, Doug Spitz, Joe Dynlacht
{"title":"In memoriam: William C. Dewey, PhD.","authors":"Dennis Leeper, Doug Spitz, Joe Dynlacht","doi":"10.1080/09553002.2022.2074564","DOIUrl":"https://doi.org/10.1080/09553002.2022.2074564","url":null,"abstract":"","PeriodicalId":14261,"journal":{"name":"International Journal of Radiation Biology","volume":"99 2","pages":"355-356"},"PeriodicalIF":2.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10596028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1080/09553002.2020.1815889
Andrey A Rosenkranz, Tatiana A Slastnikova, Mikhail O Durymanov, Georgii P Georgiev, Alexander S Sobolev
Background: The most attractive features of Auger electrons (AEs) in cancer therapy are their extremely short range and sufficiently high linear energy transfer (LET) for a majority of them. The cytotoxic effects of AE emitters can be realized only in close vicinity to sensitive cellular targets and they are negligible if the emitters are located outside the cell. The nucleus is considered the compartment most sensitive to high LET particles. Therefore, the use of AE emitters could be most useful in specific recognition of a cancer cell and delivery of AE emitters into its nucleus.
Purpose: This review describes the studies aimed at developing effective anticancer agents for the delivery of AE emitters to the nuclei of target cancer cells. The use of peptide-based conjugates, nanoparticles, recombinant proteins, and other constructs for AE emitter targeted intranuclear delivery as well as their advantages and limitations are discussed.
Conclusion: Transport from the cytoplasm to the nucleus along with binding to the cancer cell is one of the key stages in the delivery of AE emitters; therefore, several constructs for exploitation of this transport have been developed. The transport is carried out through a nuclear pore complex (NPC) with the use of specific amino acid nuclear localization sequences (NLS) and carrier proteins named importins, which are located in the cytosol. Therefore, the effectiveness of NLS-containing delivery constructs designed to provide energy-dependent transport of AE emitter into the nuclei of cancer cells also depends on their efficient entry into the cytosol of the target cell.
{"title":"Exploiting active nuclear import for efficient delivery of Auger electron emitters into the cell nucleus.","authors":"Andrey A Rosenkranz, Tatiana A Slastnikova, Mikhail O Durymanov, Georgii P Georgiev, Alexander S Sobolev","doi":"10.1080/09553002.2020.1815889","DOIUrl":"https://doi.org/10.1080/09553002.2020.1815889","url":null,"abstract":"<p><strong>Background: </strong>The most attractive features of Auger electrons (AEs) in cancer therapy are their extremely short range and sufficiently high linear energy transfer (LET) for a majority of them. The cytotoxic effects of AE emitters can be realized only in close vicinity to sensitive cellular targets and they are negligible if the emitters are located outside the cell. The nucleus is considered the compartment most sensitive to high LET particles. Therefore, the use of AE emitters could be most useful in specific recognition of a cancer cell and delivery of AE emitters into its nucleus.</p><p><strong>Purpose: </strong>This review describes the studies aimed at developing effective anticancer agents for the delivery of AE emitters to the nuclei of target cancer cells. The use of peptide-based conjugates, nanoparticles, recombinant proteins, and other constructs for AE emitter targeted intranuclear delivery as well as their advantages and limitations are discussed.</p><p><strong>Conclusion: </strong>Transport from the cytoplasm to the nucleus along with binding to the cancer cell is one of the key stages in the delivery of AE emitters; therefore, several constructs for exploitation of this transport have been developed. The transport is carried out through a nuclear pore complex (NPC) with the use of specific amino acid nuclear localization sequences (NLS) and carrier proteins named importins, which are located in the cytosol. Therefore, the effectiveness of NLS-containing delivery constructs designed to provide energy-dependent transport of AE emitter into the nuclei of cancer cells also depends on their efficient entry into the cytosol of the target cell.</p>","PeriodicalId":14261,"journal":{"name":"International Journal of Radiation Biology","volume":"99 1","pages":"28-38"},"PeriodicalIF":2.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/09553002.2020.1815889","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10723347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To clarify the radiosensitization mechanism masking the Auger effect of the cells possessing brominated DNA, the electronic properties of DNA-related molecules containing Br were investigated by X-ray spectroscopy and specific heat measurement.
Materials and methods: X-ray absorption near-edge structure (XANES) and X-ray photoemission spectroscopy (XPS) were used to measure the electronic properties of the nucleotides with and without Br. We determined the specific heat of 5-bromouracil crystals with thymine as a reference molecule at low temperatures of 3-48 K to calculate the microscopic state numbers.
Results: Obtained XANES and XPS spectra indicated that both the lowest unoccupied molecular orbital (LUMO) and the core-levels were not affected by the Br incorporation. The state numbers of 5-bromouracil calculated from the specific heats obtained around 25 K was about 1.5 times larger than that for thymine below 20 K, although the numbers were almost the same below 5 K.
Discussion: Our results suggest that the Br atom may not contribute substantially to the LUMO and core-level electronic states of the molecule, but rather to the microscopic states related to the excitation of lattice vibrations, which may be involved in valence electronic states.
{"title":"Electronic properties of DNA-related molecules containing a bromine atom.","authors":"Misaki Hirato, Misato Onizawa, Yuji Baba, Yoshinori Haga, Kentaro Fujii, Shin-Ichi Wada, Akinari Yokoya","doi":"10.1080/09553002.2020.1800121","DOIUrl":"https://doi.org/10.1080/09553002.2020.1800121","url":null,"abstract":"<p><strong>Purpose: </strong>To clarify the radiosensitization mechanism masking the Auger effect of the cells possessing brominated DNA, the electronic properties of DNA-related molecules containing Br were investigated by X-ray spectroscopy and specific heat measurement.</p><p><strong>Materials and methods: </strong>X-ray absorption near-edge structure (XANES) and X-ray photoemission spectroscopy (XPS) were used to measure the electronic properties of the nucleotides with and without Br. We determined the specific heat of 5-bromouracil crystals with thymine as a reference molecule at low temperatures of 3-48 K to calculate the microscopic state numbers.</p><p><strong>Results: </strong>Obtained XANES and XPS spectra indicated that both the lowest unoccupied molecular orbital (LUMO) and the core-levels were not affected by the Br incorporation. The state numbers of 5-bromouracil calculated from the specific heats obtained around 25 K was about 1.5 times larger than that for thymine below 20 K, although the numbers were almost the same below 5 K.</p><p><strong>Discussion: </strong>Our results suggest that the Br atom may not contribute substantially to the LUMO and core-level electronic states of the molecule, but rather to the microscopic states related to the excitation of lattice vibrations, which may be involved in valence electronic states.</p>","PeriodicalId":14261,"journal":{"name":"International Journal of Radiation Biology","volume":"99 1","pages":"82-88"},"PeriodicalIF":2.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/09553002.2020.1800121","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10727448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}